Order Article Reprints

Tani J, Senoh T, Moriya A, Ogawa C, Deguchi A, Sakamoto T, Takuma K, Nakahara M, Oura K, Tadokoro T, et al. Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) Study. Cancers. 2021; 13(9):2257. https://doi.org/10.3390/cancers13092257

Tani, Joji, Tomonori Senoh, Akio Moriya, Chikara Ogawa, Akihiro Deguchi, Teppei Sakamoto, Kei Takuma, Mai Nakahara, Kyoko Oura, Tomoko Tadokoro, and et al. 2021. "Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) Study" Cancers 13, no. 9: 2257. https://doi.org/10.3390/cancers13092257

Tani, J., Senoh, T., Moriya, A., Ogawa, C., Deguchi, A., Sakamoto, T., Takuma, K., Nakahara, M., Oura, K., Tadokoro, T., Mimura, S., Fujita, K., Yoneyama, H., Kobara, H., Morishita, A., Himoto, T., Tsutsui, A., Nagano, T., Takaguchi, K., & Masaki, T. (2021). Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) Study. Cancers, 13(9), 2257. https://doi.org/10.3390/cancers13092257